N-(2-aminophenyl)-4-[2-[[(E)-3-imidazo[1,2-a]pyridin-3-ylprop-2-enoyl]amino]ethyl]benzamide
C25H23N5O2 — CID 122181811
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2-aminophenyl)-4-[2-[[(E)-3-imidazo[1,2-a]pyridin-3-ylprop-2-enoyl]amino]ethyl]benzamide
N-(2-aminophenyl)-4-[2-[[(E)-3-imidazo[1,2-a]pyridin-3-ylprop-2-enoyl]amino]ethyl]benzamide (PubChem CID 122181811) has the molecular formula C25H23N5O2 and a molecular weight of 425.49 g/mol. Its IUPAC name is N-(2-aminophenyl)-4-[2-[[(E)-3-imidazo[1,2-a]pyridin-3-ylprop-2-enoyl]amino]ethyl]benzamide.
Molecular Properties
| Compound Name | N-(2-aminophenyl)-4-[2-[[(E)-3-imidazo[1,2-a]pyridin-3-ylprop-2-enoyl]amino]ethyl]benzamide |
|---|---|
| PubChem CID | 122181811 |
| Molecular Formula | C25H23N5O2 |
| Molecular Weight | 425.49 g/mol |
| Exact Mass | 425.19 |
| IUPAC Name | N-(2-aminophenyl)-4-[2-[[(E)-3-imidazo[1,2-a]pyridin-3-ylprop-2-enoyl]amino]ethyl]benzamide |
| SMILES | Nc1ccccc1NC(=O)c1ccc(CCNC(=O)/C=C/c2cnc3ccccn23)cc1 |
| InChI | InChI=1S/C25H23N5O2/c26-21-5-1-2-6-22(21)29-25(32)19-10-8-18(9-11-19)14-15-27-24(31)13-12-20-17-28-23-7-3-4-16-30(20)23/h1-13,16-17H,14-15,26H2,(H,27,31)(H,29,32)/b13-12+ |
| InChIKey | RAJDPDRTHFGZDV-OUKQBFOZSA-N |
| XLogP | 3.54 |
| TPSA | 101.52 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 425.49 |
| LogP ≤ 5 | 3.54 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122181811 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.